OTCMKTS:MXDHFMDxHealth Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding MDxHealth SA Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.95 0.00 (0.00 %) (As of 07/2/2020 08:47 AM ET) Add Compare Share Today's Range$0.95Now: $0.95▼$0.9550-Day Range$0.90MA: $0.93▼$0.9552-Week Range$0.65Now: $0.95▼$1.49VolumeN/AAverage Volume25 shsMarket Capitalization$67.00 millionP/E RatioN/ADividend YieldN/ABeta1.29 ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media MDxHealth SA operates as a molecular diagnostics company in Germany, the Netherlands, Poland, the United States, rest of European Union, and internationally. The company develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. Its tests are based on genetic, epigenetic (methylation) and other molecular technologies, and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The company's product pipeline includes tests for prostate, bladder, kidney, cervical, and brain cancers. Its products include ConfirmMDx, a tissue-based epigenetic test for prostate cancer; SelectMDx, a urine-based mRNA test for prostate cancer; and AssureMDx bladder cancer detection test for patients with unresolved hematuria. The company's preclinical development products comprise InformMDx, a tissue-based gene expression panel for prostate cancer; SelectMDx assay to a point of care testing platform; and MonitorMDx, a blood-based test for prostate cancer. It has collaboration agreement with 3D Signatures Inc. to evaluate prognostic test candidate for prostate cancer. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was founded in 2003 and is headquartered in Herstal, Belgium.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for MDxHealth. Previous Next 2.1 Community Rank Outperform VotesMDxHealth has received 59 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMDxHealth has received 81 “underperform” votes. (Add your “underperform” vote.)Community SentimentMDxHealth has received 57.86% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about MDxHealth and other stocks. Vote “Outperform” if you believe MXDHF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MXDHF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMDxHealth does not currently pay a dividend.Dividend GrowthMDxHealth does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, MDxHealth insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for MDxHealth are expected to grow in the coming year, from ($0.39) to ($0.31) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MDxHealth is -1.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MDxHealth is -1.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMDxHealth has a P/B Ratio of 2.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.55 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MXDHF Previous SymbolNASDAQ:MXDHF CUSIPN/A CIKN/A Webwww.mdxhealth.com Phone32042577021Debt Debt-to-Equity Ratio0.50 Current Ratio2.97 Quick Ratio2.86Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$11.78 million Price / Sales5.69 Cash FlowN/A Price / Cash FlowN/A Book Value$0.33 per share Price / Book2.88Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares70,530,000Market Cap$67.00 million Next Earnings DateN/A OptionableNot Optionable OTC:MXDHF Rates by TradingView Receive MXDHF News and Ratings via Email Sign-up to receive the latest news and ratings for MXDHF and its competitors with MarketBeat's FREE daily newsletter. MDxHealth (OTCMKTS:MXDHF) Frequently Asked Questions How has MDxHealth's stock been impacted by COVID-19 (Coronavirus)? MDxHealth's stock was trading at $1.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MXDHF shares have decreased by 13.6% and is now trading at $0.95. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of MDxHealth? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for MDxHealth. Has MDxHealth been receiving favorable news coverage? News articles about MXDHF stock have trended very negative on Thursday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. MDxHealth earned a news impact score of -3.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about MDxHealth. Who are some of MDxHealth's key competitors? Some companies that are related to MDxHealth include LONMIN PLC/S (LNMIY), Capstone Mining (CSFFF), NEXCF (NEXCF), PARKSON RETAIL/ADR (PKSGY), Poxel (PXXLF), EAGLE POINT CR/COM (ECC), Integra Resrcs (IRRZF), SUPERDRY PLC/ADR (SEPGY), NicOx (NICXF), FOXTONS GRP PLC/ADR (FXTGY), ESPRIT HOLDINGS/S (ESPGY), TAIWAN FD INC/SH (TWN), Bank Of Princeton (BPRN), NOBLE GRP LTD/ADR (NOBGY) and Paladin Energy (PALAF). View all competitors. Who are MDxHealth's key executives? MDxHealth's management team includes the following people: Mr. Michael K. McGarrity, CEO & Director (Age 56)Mr. Kurt Schmidt, Exec. VP of Fin. & Interim CFO (Age 58)Dr. Wim Van Criekinge, Chief Scientific Officer (Age 47)Mr. Joseph Sollee, Chief Compliance Officer, Exec. VP of Corp. Devel. & Gen. Counsel (Age 54)Mr. Jean-Marc Roelandt, CFO & Exec. VP (Leave of Absence) (Age 54) What is MDxHealth's stock symbol? MDxHealth trades on the OTCMKTS under the ticker symbol "MXDHF." How do I buy shares of MDxHealth? Shares of MXDHF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is MDxHealth's stock price today? One share of MXDHF stock can currently be purchased for approximately $0.95. How big of a company is MDxHealth? MDxHealth has a market capitalization of $67.00 million and generates $11.78 million in revenue each year. The company earns $-43,100,000.00 in net income (profit) each year or ($0.53) on an earnings per share basis. What is MDxHealth's official website? The official website for MDxHealth is www.mdxhealth.com. How can I contact MDxHealth? MDxHealth's mailing address is CAP Business Center Rue d`Abhooz 31, Herstal C9, 4040. The company can be reached via phone at 32042577021 or via email at [email protected] This page was last updated on 7/2/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
